Cambrex Corporation
Cambrex is a global CDMO that provides drug substance, drug product and analytical services across the entire drug lifecycle.
Basic Information
- Category: Fine Chemicals
- Founded: 1981
- Headquarters: East Rutherford, NJ
- Website: cambrex.com
Documented Facts
- Phone: 201-804-3000 (No linked source recorded for this statement.)
- Email: info@cambrex.com (No linked source recorded for this statement.)
- Team Size: 2 (No linked source recorded for this statement.)
Evidence and Sources
- Cambrex Corporation — Official Site (official)
- Cambrex Corporation on linkedin (social)
Citation Guidance
Explore Fine Chemicals profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Cambrex Corporation.
- Canonical profile: https://brandsource.ai/brands/cambrex-corporation
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/cambrex-corporation/json-ld
- Citation profile API: https://brandsource.ai/api/brands/cambrex-corporation/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (87/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T19:08:19.715Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Cambrex is a global CDMO that provides drug substance, drug product and analytical services across the entire drug lifecycle.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.